Showing results (101-110 of 171) with videos related to
Sort By:
Pageof 18
British Journal of Clinical Pharmacology|October 1, 1983
Plasma digoxin: assay anomalies in Fab-treated patientsI Gibb, P C Adams, A J Parnham, et al.Journal of the American College of Cardiology|December 1, 1986
Thrombosis and embolism from cardiac chambers and infected valvesP C Adams, M Cohen, J H Chesebro, et al.Current Medical Research and Opinion|February 24, 2001
Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study)F Garmendia, A S Brown, I Reiber, et al.American Journal of Hematology|August 1, 1991
Expression of transferrin receptors on monocytes in hemochromatosisP C Adams, L A Chau, M White, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1991
The effect of human recombinant erythropoietin on iron absorption and hepatic iron in a rat modelP C Adams, L A Chau, E Lin, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Hepatic iron and iron absorption in hemochromatosisP C Adams, J V Frei, C Bradley, et al.Clinical Genetics|January 6, 2007
Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithmsG Gagné, D Reinharz, N Laflamme, et al.The Quarterly Journal of Medicine|September 1, 1993
Plasma potassium, serum magnesium and ventricular fibrillation: a prospective studyP D Higham, P C Adams, A Murray, et al.The American Journal of Cardiology|December 1, 1990
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group)M Cohen, P C Adams, L Hawkins, et al.Annals of Internal Medicine|July 15, 1997
Clinical features of genetic hemochromatosis in women compared with menR Moirand, P C Adams, V Bicheler, et al.Pageof 18